Estadisticas : Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study

Martín, Miguel
Visitas:268
147 ( Estados Unidos de América )
37 ( Hong kong )
34 ( Singapur )
8 ( Letonia )
8 ( Brasil )
7 ( Francia )
7 ( Finlandia )
5 ( Alemania )
4 ( México )
3 ( China )
3 ( Reino Unido )
2 ( Indonesia )
1 ( Irlanda )
1 ( España )
1 ( Austria )
Descargas: 141